3623 results for «2520»
3623 results
CT guidance for coronary intervention and surgery
27 Jun 2020 – From PCr e-Course 2020
Find out how coronary CT can be used for selection of coronary revascularisation procedures and how it can help planning the procedural strategy for PCI of bifurcation and complex lesions.
This session was originally presented during PCR e-Course 2020.
TAVI for bicuspid valves with Evolut: BIVOLUT-X registry
Learn more about transcatheter treatment of bicuspid aortic valves with the EVOLUT platform, the BIVOLUT-X registry design, and key outcomes and practical implications of the study.
Videos included on this page: the Hot Line presentation and an Investigator Perspective.
How to select the most appropriate DAPT strategy in each patient?
Watch this case discussion if you want to tailor DAPT strategies based on balance between ischaemic and bleeding risks in specific clinical situations and to review the different options regarding drug choices, doses, and duration of treatment.
This session was originally presented during PCR e-Course 2020.
TAVI patients and procedures in 2020 and beyond – leading with Evolut platform
Watch this session if you want to learn about the importance of haemodynamics & DVI correlation to mortality in TAVI patients and to learn practical procedural tips & techniques to achieve superior outcomes & early discharge.
Prevention and management of complications during valvular and structural interventions
26 Jun 2020 – From PCR e-Course 2020
Watch this case discussion to understand how to avoid complications, to assess how to recognise complications early and to identify how to handle complications scenarios.
This session was originally presented during PCR e-Course 2020.
Case Based Learning for the Heart Team: coronary artery disease in TAVI patients
25 Jun 2020 – From PCR e-Course 2020
Watch this case discussion to understand the practical implications of coronary artery disease in TAVI patients, to recognise different situations where this interaction directly impacts on clinical outcomes and to appreciate how to apply this information in your daily clinical practice.
This session was originally presented during...
Non-culprit stenosis revascularisation in STEMI patients with multivessel disease: which, when and how?
26 Jun 2020 – From PCR e-Course 2020
Watch this case discussion if you want to understand how to invasively evaluate non-culprit stenosis in STEMI, to discuss optimal timing of non-culprit PCI and to understand how to implement novel evidence and guideline recommendations to your local practice.
This session was originally presented during PCR e-Course...
Prevention and management of coronary complications
25 Jun 2020 – From PCR e-Course 2020
Watch this session to discover clinical cases with different PCI-related complications, and learn how to minimise their risks and how to best manage them.
This session was originally presented during PCR e-Course 2020.
How should aortic stenosis be treated in the modern era and what is the role of the heart team?
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to gain insight into the current status of aortic stenosis treatment around the world, to learn more about the patient and treatment selection by the Heart Team, and to discover how the patient pathway's optimization may facilitate the increasing demand for TAVR.
How to optimise coronary intervention therapy with SAPIEN 3
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn through various challenging cases about the optimal timing for performing coronary intervention for TAVI patients, the coronary access techniques for SAPIEN 3 patients and the differences in coronary access between balloon- and self-expandable devices.
Valve selection for patients with longer life
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about patients with failed surgical bioprosthesis valves' treatment, valve selection impacts clinical and procedural outcomes, and discover some future trends in treating TAVI patients with longer life expectancy which may revolutionize your practice.
TAVI as cutting edge
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn all about LOTUS Edge's current status, long term outcome in japan, and clinical use thanks to a selection of challenging cases.
Antithrombotic therapy for AF in bioprosthetic valve
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the anticoagulant therapy for bioprosthetic valves with AF, the optimal stroke prevention strategy after TAVI and the clinical impact of the current data on leaflet thrombosis.
Learnings from a decade-long experience of transcatheter mitral valve repair procedures with MitraClipTM
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the patient selection and procedure for MitraClip, and discover how to decide endpoint and assess procedural outcome after this intervention, and how to avoid potential complications, such as chordal entanglement.
Sizes, wires, and other innovations in TAVI technique and technology
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session on innovations in TAVI technique and technology to learn more about new self-expanding TAVR valve sizes and TAVR wires, emerging developments in self-expandable TAVR implant best practices, and discover how to utilize these new technologies and techniques to achieve the best possible outcomes for AS patients.
MitraClip case in point in Japanese
16 Feb 2020 – From PCR Tokyo Valves 2020
Find out more on the MitraClip NT System Japan post market surveillance, the MitraClip best practice and challenging functional MR cases...
Beyond the evolution! Latest image guided therapy for structural heart disease intervention 2.0 era
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session in japanese to learn more about EchoNavigator, an innovative tool for guidance of interventional procedures in structural heart disease, and discover how it may help you achieve a better patient outcome.
Imaging Day - Case-based imaging for the mitral valve
14 Feb 2020 – From PCR Tokyo Valves 2020
Which imaging is most relevant to clinical decision-making and procedural planning? Find out more on the pathophysiology of mitral regurgitation.
Remaining challenges in TAVI: how to achieve the better lifetime outcomes for AS patients
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to gain insight into the remaining challenges in TAVI, such as providing AS patients with the best possible outcomes over their entire lifetime, improving pacemaker implant rates with self-expandable valves, and more!
Cases in Japanese - PCI, MR & TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: PCI for coronary ischemia after EvolutR implantation, degenerative mitral regurgitation with large gap, bailout of ventricular septal defect after TAVI, and more!
